Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Lipid Efficacy/Tolerability Study (0524A-020)

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Merck Sharp & Dohme Corp.
ClinicalTrials.gov Identifier:
NCT00269204
First received: December 21, 2005
Last updated: July 24, 2015
Last verified: July 2015